drugset / Trial / NCT00641472
Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children
RandomizedParallel-groupOpen-labelTreatment
Summary
A one year study comparing the safety and effectiveness of Pulmicort (0.5mg strength given once a day in the evening) with either 4 or 5mg strength SINGULAR (given once a day in the evening) in children with asthma aged 2 to 8. If allocated to SINGULAR treatment, children aged between 2 and 5 will receive 4mg strength SINGULAR and those aged between 6 and 8 will receive 5mg strength SINGULAR.
Timeline
- Start
- 2002-10
- Primary completion
- 2005-02
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 0.5 mg | — |
| Comparator | Montelukast | Other / unclassified | 4 mg | — |
| Comparator | Montelukast | Other / unclassified | 5 mg | — |